{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:25:39Z","timestamp":1743827139557,"version":"3.40.3"},"reference-count":24,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T00:00:00Z","timestamp":1342656000000},"content-version":"vor","delay-in-days":6105,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[1995,11]]},"abstract":"<jats:p><jats:list list-type=\"explicit-label\"><jats:list-item><jats:p>Besipirdine (HP 749) is a compound undergoing clinical trials for efficacy in treating Alzheimer's disease. Among other pharmacological effects, besipirdine inhibits voltage\u2010dependent sodium and potassium channels. This paper presents a pharmacological study of the interaction of besipirdine with voltage\u2010dependent sodium channels.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Besipirdine inhibited [<jats:sup>3<\/jats:sup>H]\u2010batrachotoxin binding (IC<jats:sub>50<\/jats:sub>= 5.5\u00b10.2 \u03bc<jats:sc>m<\/jats:sc>) in a rat brain vesicular preparation and concentration\u2010dependently inhibited veratridine (25 \u03bc<jats:sc>m<\/jats:sc>)\u2010stimulated increases in intracellular free sodium ([Na<jats:sup>+<\/jats:sup>]<jats:sub>i<\/jats:sub>) and calcium ([Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub>) in primary cultured cortical neurones of rat.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Besipirdine (30\u2013100 \u03bc<jats:sc>m<\/jats:sc>) concentration\u2010dependently inhibited (up to 100%) veratridine\u2010stimulated release of [<jats:sup>3<\/jats:sup>H]\u2010noradrenaline (NA) from rat cortical slices.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>When examined in greater detail, besipirdine was found to inhibit [<jats:sup>3<\/jats:sup>H]\u2010batrachotoxin binding in vesicular membranes competitively. However, when examined in rat brain synaptosomes, we found that the antagonism by besipirdine was not competitive; that is, the maximal stimulation of [Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub>induced by veratridine decreased with increasing concentrations of besipirdine.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>These results show that besipirdine is an inhibitor of voltage\u2010sensitive sodium channels and appears to bind to a site close to the batrachotoxin\/veratridine binding site.<\/jats:p><\/jats:list-item><\/jats:list><\/jats:p>","DOI":"10.1111\/j.1476-5381.1995.tb15097.x","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T02:40:17Z","timestamp":1342752017000},"page":"2468-2472","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of besipirdine at the voltage\u2010dependent sodium channel"],"prefix":"10.1111","volume":"116","author":[{"given":"L.","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.P.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.P.","family":"Huger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kongsamut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,19]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.06-07-02064.1986"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7742(08)60084-7"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.1016\/S0021-9258(19)75273-9","article-title":"Activation of action potential sodium ionophore by neurotoxins: an allosteric model. J","volume":"252","author":"CATTERALL W.A.","year":"1977","journal-title":"Biol. Chem."},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.55.070186.004513"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(87)90011-3"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"8922","DOI":"10.1016\/S0021-9258(19)52487-5","article-title":"Binding of batrachotoxinin\u2010A 20\u2010\u03b1\u2010benzoate to a receptor site associated with sodium channels in synaptic nerve ending particles","volume":"256","author":"CATTERALL W.A.","year":"1981","journal-title":"J. Biol. Chem."},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490350513"},{"key":"e_1_2_1_9_1","first-page":"612","article-title":"HP 749 (I): A Pharmacological profile of a therapeutic agent for Alzheimer's disease","volume":"16","author":"CORNFELDT M.","year":"1990","journal-title":"Soc. Neurosci. Abstr."},{"key":"e_1_2_1_10_1","first-page":"350","article-title":"Batrachotoxin\u2010induced depolarization and [3H]batrachotoxinin\u2010A 20\u03b1\u2010benzoate binding in a vesicular preparation from guinea\u2010pig cerebral cortex","volume":"23","author":"CREVELING C.R.","year":"1983","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_1_11_1","unstructured":"EFFLAND R.C. KLEIN J.T. DAVIS L.&OLSEN G.E.(1990).N\u2010(pyridinyl)\u20101H\u2010indol amines.U.S. Patent No. 4 970 218."},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1001\/jama.1989.03430180093036","article-title":"Prevalence of Alzheimer's disease in a community of older persons. Higher than previously reported. J","volume":"262","author":"EVANS D.A.","year":"1989","journal-title":"Am. Med. Ass."},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00171088"},{"key":"e_1_2_1_14_1","first-page":"612","article-title":"HP749. A potential therapeutic agent for Alzheimer's disease: II. Neurochemical profile","volume":"16","author":"HUGER F.P.","year":"1990","journal-title":"Soc. Neurosci. Abstr."},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(88)90198-8"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-3565(25)38428-4","article-title":"Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells","volume":"266","author":"LANG D.G.","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_17_1","first-page":"225","volume-title":"Biochemistry","author":"LEHNINGER A.L.","year":"1982"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00028a010"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199114001-00002"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3565(25)38464-8","article-title":"Class I antiarrhythmic drugs: allosteric inhibitors of [3H]batrachotoxinin binding to rat cardiac sodium channels","volume":"268","author":"SHELDON R.S.","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01006816"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.430320104"},{"key":"e_1_2_1_23_1","first-page":"97","article-title":"Design and use of a new electroshock seizure apparatus and analysis of factors altering seizure threshold and pattern","volume":"92","author":"WOODBURY L.A.","year":"1952","journal-title":"Arch. Int. Pharmacodyn."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.430290306"},{"key":"e_1_2_1_25_1","first-page":"73","volume-title":"Chemical and Functional assays of Receptor Binding, Short Course 1 Syllabus","author":"ZAHNISER N.R.","year":"1986"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.1995.tb15097.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.1995.tb15097.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T23:41:59Z","timestamp":1743810119000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.1995.tb15097.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,11]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1995,11]]}},"alternative-id":["10.1111\/j.1476-5381.1995.tb15097.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.1995.tb15097.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"type":"print","value":"0007-1188"},{"type":"electronic","value":"1476-5381"}],"subject":[],"published":{"date-parts":[[1995,11]]},"assertion":[{"value":"2012-07-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}